Test could predict which children with T-cell ALL are best candidates for clinical trials
Saturday, July 24, 2010 - 20:35
in Health & Medicine
A genetic clue uncovered by scientists enables doctors to predict, for the first time, which children with T-cell acute lymphoblastic leukemia (T-ALL) are unlikely to benefit from standard chemotherapy for the disease and should therefore be among the first to receive new treatments in future clinical trials.